Can I read Merck Suspends TREDAPTIVE Availability on EtoBox?

Merck Suspends TREDAPTIVE Availability by angelmarroman is a document available to read on EtoBox.

What is Merck Suspends TREDAPTIVE Availability about?

Merck announced the suspension of TREDAPTIVE™ (extended-release niacin/laropiprant) tablets worldwide due to findings from the HPS2-THRIVE study, which did not meet its primary endpoint and showed an increase in non-fatal serious adverse events. The company is advising physicians to stop prescribing TREDAPTIVE and review treatment plans for patients currently using the medication. Merck is working with regulatory agencies to ensure proper communication regarding this decision.

Author

angelmarroman

Language

EN